immun

/immun

About immun

This author has not yet filled in any details.
So far immun has created 9 blog entries.

사노피 출신 대표가 이끌고, 유한이 선택한 ‘그 회사’

By | 2019/10/21|News and Publications|

ImmuneOncia has been selected by the Korea Drug Development Fund to develop an immune therapy targeting a cancer-aiding protein.

By | 2019/09/19|News and Publications|

Yuhan Corp and Sorrento Therapeutics announce completion of phase 1 clinical study of anti-PD-L1 antibody IMC-001

By | 2019/03/20|News and Publications|

Yuhan Corp and Sorrento Therapeutics announce closing of a $40M USD Financing for joint venture ImmuneOncia to support advancement of Immuno-Oncology program

By | 2019/02/18|News and Publications|

Sorrento’s and Yuhan’s joint venture, ImmuneOncia, receives approval to begin clinical trial of anti-PD-L1 monoclonal antibody in South Korea

By | 2018/03/07|News and Publications|

The March 2018 edition of BioPharma Dealmakers

By | 2018/03/07|News and Publications|

A PD-L1 latecomer hoping to break into the market

By | 2017/11/20|News and Publications|

ImmuneOncia “First anti-PD-L1 immunotherapy drug in Korea, clinical phase next year”

By | 2017/09/04|News and Publications|

Yuhan Corporation And Sorrento Therapeutics Form Joint Venture Company – ImmuneOncia

By | 2017/02/21|News and Publications|